Endoprevention of esophageal cancer: endoscopic ablation of Barrett’s metaplasia and dysplasia

References

• Bond JH. Interference with the adenoma-carcinoma sequence. Eur. J. Cancer 31A, 1115–1117 (1995).
   Google Scholar
• Winawer SJ, Zauber AG, Ho MN et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N. Engl. J. Med. 329, 1977–1981 (1993).
   PubMed Web of Science ®Google Scholar
• Rex DK, Johnson DA, Lieberman DA, Burt RW, Sonnenberg A. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. Am. J. Gastroenterol. 95, 868–877 (2000).
   PubMed Web of Science ®Google Scholar
• US Preventative Services Task Force. Screening for colorectal cancer: recommendation and rationale. Ann. Intern. Med. 137, 129–131 (2002).
   PubMed Web of Science ®Google Scholar
• Wolfsen HC. Present status of photodynamic therapy for high-grade dysplasia in Barrett’s esophagus. J. Clin. Gastroenterol. 39, 189–202 (2005).
   PubMedGoogle Scholar
• Jemal A, Murray T, Ward E et al. Cancer statistics, 2005. Cancer J. Clin. 55, 10–30 (2005).
   PubMed Web of Science ®Google Scholar
• Brown LM, Devesa SS. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg. Oncol. Clin. N. Am. 11, 235–256 (2002).
   PubMedGoogle Scholar
• Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. J. Am. Med. Assoc. 265, 1287–1289 (1991).
   PubMed Web of Science ®Google Scholar
• Pacifico RJ, Wang KK. Nonsurgical management of Barrett’s esophagus with high-grade dysplasia. Surg. Oncol. Clin. N. Am. 11, 321–336 (2002).
   Google Scholar
• Shaheen NJ. Advances in Barrett’s esophagus and esophageal adenocarcinoma. Gastroenterology 128, 1554–1566 (2005).
   PubMed Web of Science ®Google Scholar
• Drewitz DJ, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett’s esophagus: a prospective study of 170 patients followed 4.8 years. Am. J. Gastroenterol. 92, 212–215 (1997).
   PubMed Web of Science ®Google Scholar
• Weston AP, Banerjee SK, Sharma P, Tran TM, Richards R, Cherian R. p53 protein overexpression in low grade dysplasia (LGD) in Barrett’s esophagus: immunohistochemical marker predictive of progression. Am. J. Gastroenterol. 96, 1355–1362 (2001).
   PubMed Web of Science ®Google Scholar
• Reid BJ, Levine DS, Longton G, Blount PL, Rabinovitch PS. Predictors of progression to cancer in Barrett’s esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. Am. J. Gastroenterol. 95, 1669–1676 (2000).
   PubMed Web of Science ®Google Scholar
• Skacel M, Petras RE, Gramlich TL et al. The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression. Am. J. Gastroenterol. 95, 3383–3387 (2000).
   PubMed Web of Science ®Google Scholar
• da Silva VD, Prolla JC, Sharma P, Sampliner R, Thompson D, Bartels PH. Karyometry in Barrett’s esophagus. Anal. Quant. Cytol. Histol. 23, 40–46 (2001).
   Google Scholar
• Garewal HS, Sampliner R, Liu Y, Trent JM. Chromosomal rearrangements in Barrett’s esophagus. A premalignant lesion of esophageal adenocarcinoma. Cancer Genet. Cytogenet. 42, 281–286 (1989).
   PubMedGoogle Scholar
• Wild CP, Hardie LJ. Reflux, Barrett's oesophagus and adenocarcinoma: burning questions. Nat. Rev. Cancer 3, 676–684 (2003).
   PubMed Web of Science ®Google Scholar
• Olliver JR, Hardie LJ, Gong Y et al. Risk factors, DNA damage, and disease progression in Barrett’s esophagus. Cancer Epidemiol. Biomarkers Prev. 14, 620–625 (2005).
   PubMed Web of Science ®Google Scholar
• Urbach DR, Baxter NN. Does it matter what a hospital is “high volume” for? Specificity of hospital volume-outcome associations for surgical procedures: analysis of administrative data. Br. Med. J. 328, 737–740 (2004).
   Google Scholar
• Bartels H, Stein HJ, Siewert JR. Risk analysis in esophageal surgery. Recent Results Cancer Res. 155, 89–96 (2000).
   PubMedGoogle Scholar
• Dimick JB, Wainess RM, Upchurch GR Jr, Iannettoni MD, Orringer MB. National trends in outcomes for esophageal resection. Ann. Thorac. Surg. 79, 212–216 (2005).
   Google Scholar
• Lerut TE, van Lanschot JJ. Chronic symptoms after subtotal or partial oesophagectomy: diagnosis and treatment. Best Pract. Res. Clin. Gastroenterol. 18, 901–915 (2004).
   PubMed Web of Science ®Google Scholar
• Orringer MB, Marshall B, Iannettoni MD. Eliminating the cervical esophagogastric anastomotic leak with a side-to-side stapled anastomosis. J. Thorac. Cardiovasc. Surg. 119, 277–288 (2000).
   PubMed Web of Science ®Google Scholar
• Ikeguchi M, Maeta M, Kaibara N. Respiratory function after esophagectomy for patients with esophageal cancer. Hepatogastroenterology 49, 1284–1286 (2002).
   Google Scholar
• Shibuya S, Fukudo S, Shineha R et al. High incidence of reflux esophagitis observed by routine endoscopic examination after gastric pull-up esophagectomy. World J. Surg. 27, 580–583 (2003).
   PubMed Web of Science ®Google Scholar
• Wolfsen HC, Hemminger LL, DeVault KR. Recurrent Barrett’s esophagus and adenocarcinoma after esophagectomy. BMC Gastroenterol. 4, 18 (2004).
   Google Scholar
• De Leyn P, Coosemans W, Lerut T. Early and late functional results in patients with intrathoracic gastric replacement after oesophagectomy for carcinoma. Eur. J. Cardiothorac. Surg. 6, 79–84 (1992).
   PubMed Web of Science ®Google Scholar
• DeVault KR, Ward EM, Wolfsen HC et al. Barrett’s esophagus (BE) is common in older patients undergoing screening colonoscopy regardless of gastroesophageal reflux (GER) symptoms. Gastrointest. Endosc. 59, AB111 (2004).
   Google Scholar
• Conio M, Lapertosa G, Blanchi S, Filiberti R. Barrett’s esophagus: an update. Crit. Rev. Oncol. Hematol. 46, 187–206 (2003).
   PubMedGoogle Scholar
• Barrett NR. Chronic peptic ulcer of the oesophagus and ‘oesophagitis’. Br. J. Surg. 38, 175–182 (1950).
   PubMed Web of Science ®Google Scholar
• Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett’s) esophagus. N. Engl. J. Med. 313, 857–859 (1985).
   PubMed Web of Science ®Google Scholar
• Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N. Engl. J. Med. 340, 825–831 (1999).
   PubMed Web of Science ®Google Scholar
• Sampliner RE. Long-term endoscopic surveillance of Barrett’s esophagus. Am. J. Gastroenterol. 98, 1912–1913 (2003).
   Google Scholar
• Corley DA, Levin TR, Habel LA, Weiss NS, Buffler PA. Surveillance and survival in Barrett’s adenocarcinomas: a population-based study. Gastroenterology 122, 633–640 (2002).
   PubMed Web of Science ®Google Scholar
• Dulai GS, Guha S, Kahn KL, Gornbein J, Weinstein WM. Preoperative prevalence of Barrett’s esophagus in esophageal adenocarcinoma: a systematic review. Gastroenterology 122, 26–33 (2002).
   PubMed Web of Science ®Google Scholar
• Solaymani-Dodaran M, Logan RF, West J, Card T, Coupland C. Risk of oesophageal cancer in Barrett’s oesophagus and gastro-oesophageal reflux. Gut 53, 1070–1074 (2004).
   PubMed Web of Science ®Google Scholar
• Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett’s esophagus in asymptomatic individuals. Gastroenterology 123, 461–467 (2002).
   PubMed Web of Science ®Google Scholar
• Rex DK, Cummings OW, Shaw M et al. Screening for Barrett’s esophagus in colonoscopy patients with and without heartburn. Gastroenterology 125, 1670–1677 (2003).
   PubMed Web of Science ®Google Scholar
• DeVault KR, Ward EM, Wolfsen HC et al. Symptoms do not predict the presence of Barrett’s esophagus in older patients undergoing colonoscopy. Am. J. Gastroenterol. 98, S13 (2003).
   Google Scholar
• Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA. Prevalence of columnar-lined (Barrett’s) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology 99, 918–922 (1990).
   PubMed Web of Science ®Google Scholar
• Ormsby AH, Kilgore SP, Goldblum JR, Richter JE, Rice TW, Gramlich TL. The location and frequency of intestinal metaplasia at the esophagogastric junction in 223 consecutive autopsies: implications for patient treatment and preventive strategies in Barrett’s esophagus. Mod. Pathol. 13, 614–620 (2000).
   Google Scholar
• Wolfsen HC, Hemminger LL, DeVault KR. Barrett’s dysplasia and mucosal carcinoma patients referred for photodynamic therapy – do they come from surveillance programs? Gastrointest. Endosc. 59, AB265 (2004).
   Google Scholar
• Inadomi JM, Sampliner R, Lagergren J, Lieberman D, Fendrick AM, Vakil N. Screening and surveillance for Barrett esophagus in high-risk groups: a cost–utility analysis. Ann. Intern. Med. 138, 176–186 (2003).
   PubMed Web of Science ®Google Scholar
• Provenzale D, Schmitt C, Wong JB. Barrett’s esophagus: a new look at surveillance based on emerging estimates of cancer risk. Am. J. Gastroenterol. 94, 2043–2053 (1999)
   PubMed Web of Science ®Google Scholar
• Prosst RL, Wolfsen HC, Gahlen J. Photodynamic therapy for esophageal diseases: a clinical update. Endoscopy 35, 1059–1068 (2003).
   Google Scholar
• Dulai G, Jensen D, Saad M, Mawas I, Yu J, Fontana L. Simultaneous screening for Barrett’s and colorectal cancer. Gastrointest. Endosc. 59, AB259 (2004).
   Google Scholar
• Geboes K, Van Eyken P. The diagnosis of dysplasia and malignancy in Barrett’s oesophagus. Histopathology 37, 99–107 (2000).
   PubMedGoogle Scholar
• Shaheen N, Ransohoff DF. Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: scientific review. J. Am. Med. Assoc. 287, 1972–1981 (2002).
   PubMed Web of Science ®Google Scholar
• Gross CP, Cruz-Correa M, Canto MI, McNeil-Solis C, Valente TW, Powe NR. The adoption of ablation therapy for Barrett’s esophagus: a cohort study of gastroenterologists. Am. J. Gastroenterol. 97, 279–286 (2002).
   PubMed Web of Science ®Google Scholar
• Schnell TG, Sontag SJ, Chejfec G et al. Long-term nonsurgical management of Barrett’s esophagus with high-grade dysplasia. Gastroenterology 120, 1607–1619 (2001).
   PubMed Web of Science ®Google Scholar
• Fang M, Lew E, Klein M, Sebo T, Su Y, Goyal R. DNA abnormalities as marker of risk for progression of Barrett’s esophagus to adenocarcinoma: image cytometric DNA analysis in formalin-fixed tissues. Am. J. Gastroenterol. 99, 1887–1894 (2004).
   Google Scholar
• Siersema PD. Endoscopic therapeutic esophageal interventions: something old, something new, something to be established. Curr. Opin. Gastroenterol. 20, 397–403 (2004).
   Google Scholar
• Wang K. Photodynamic therapy made simple. Clin. Perspec. Gastroenterol. 90–100 (2001).
   Google Scholar
• Webber J, Herman M, Kessel D, Fromm D. Current concepts in gastrointestinal photodynamic therapy. Ann. Surg. 230, 12–23 (1999).
   Google Scholar
• Overholt BF, Panjehpour M, Haydek JM. Photodynamic therapy for Barrett’s esophagus: follow-up in 100 patients. Gastrointest. Endosc. 49, 1–7 (1999).
   PubMed Web of Science ®Google Scholar
• Malhi-Chowla N, Wolfsen HC, DeVault KR. Esophageal dysmotility in patients undergoing photodynamic therapy. Mayo Clin. Proc. 76(10), 987–989 (2001).
   Google Scholar
• Wolfsen HC, Hemminger LL. Photodynamic therapy for dysplastic Barrett’s esophagus and mucosal adenocarcinoma. Gastrointest. Endosc. 59, AB251 (2004).
   Google Scholar
• Wang KK, Wong Kee Song LM, Buttar NS, Papenfuss S, Lutzke L. Barrett’s esophagus after photodynamic therapy: risk of cancer development during long term follow up. Gastroenterology 126(Suppl. 2), A50 (2004).
   Google Scholar
• Ukleja A, Scolapio JS, Wolfsen HC. Endoscopic ultrasonography (EUS) and endoscopic mucosal resection (EMR) for staging and treatment of high-grade dysplasia (HGD) and early adenocarcinoma (EAC) in Barrett’s esophagus (BE). Gastrotenterology 116, A582 (1999).
   Google Scholar
• Nijhawan PK, Wolfsen HC, Wang KK, Buttar NS, Lutzke L, Anderson M. Cutaneous photosensitivity after photodynamic therapy: is it really more common in sunny climates? Gastroenterology 118, A227 (2000).
   Google Scholar
• Mang TS. Laser and light sources for PDT. Photodiag. Photodyn. Ther. 43–48 (2004).
   Google Scholar
• Chen X, Yang CS. Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention. Carcinogenesis 22, 1119–1129 (2001).
   PubMedGoogle Scholar
• Panjehpour M, Overholt BF, Haydek JM, Lee SG. Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett’s esophagus and effect of oral steroids on stricture formation. Am. J. Gastroenterol. 95, 2177–2184 (2000).
   PubMed Web of Science ®Google Scholar
• Wolfsen HC. Photodynamic therapy for mucosal esophageal adenocarcinoma and dysplastic Barrett’s esophagus. Dig. Dis. 20, 5–17 (2002).
   Google Scholar
• Hur C, Nishioka NS, Gazelle GS. Cost–effectiveness of photodynamic therapy for treatment of Barrett’s esophagus with high grade dysplasia. Dig. Dis. Sci. 48, 1273–1283 (2003).
   PubMed Web of Science ®Google Scholar
• Sampliner RE. Epidemiology, pathophysiology, and treatment of Barrett’s esophagus: reducing mortality from esophageal adenocarcinoma. Med. Clin. North Am. 89, 293–312 (2005).
   Google Scholar
• Sampliner RE. Prevention of adenocarcinoma by reversing Barrett’s esophagus with mucosal ablation. World J. Surg. 27, 1026–1029 (2003).
   PubMed Web of Science ®Google Scholar
• Sampliner RE. Management of premalignant esophagogastric lesions. Ariz. Med. 39, 312–313 (1982).
   Google Scholar
• Garewal H, Ramsey L, Sharma P, Kraus K, Sampliner R, Fass R. Biomarker studies in reversed Barrett’s esophagus. Am. J. Gastroenterol. 94, 2829–2833 (1999).
   PubMed Web of Science ®Google Scholar
• Sampliner RE, Hixson LJ, Fennerty MB, Garewal HS. Regression of Barrett’s esophagus by laser ablation in an acid environment. Dig. Dis. Sci. 38, 365–368 (1993).
   PubMed Web of Science ®Google Scholar
• Brandt LJ, Kauvar DR. Laser-induced transient regression of Barrett’s epithelium. Gastrointest. Endosc. 38, 619–622 (1992).
   PubMedGoogle Scholar
• Soetikno RM, Gotoda T, Nakanishi Y, Soehendra N. Endoscopic mucosal resection. Gastrointest. Endosc. 57, 567–579 (2003).
   PubMed Web of Science ®Google Scholar
• Conio M, Cameron AJ, Chak A, Blanchi S, Filiberti R. Endoscopic treatment of high-grade dysplasia and early cancer in Barrett’s oesophagus. Lancet Oncol. 6, 311–321 (2005).
   PubMed Web of Science ®Google Scholar
• May A, Gossner L, Behrens A et al. A prospective randomized trial of two different endoscopic resection techniques for early stage cancer of the esophagus. Gastrointest. Endosc. 58, 167–175 (2003).
   PubMed Web of Science ®Google Scholar
• Rosch T, Sarbia M, Schumacher B et al. Attempted endoscopic en bloc resection of mucosal and submucosal tumors using insulated-tip knives: a pilot series. Endoscopy 36, 788–801 (2004).
   PubMed Web of Science ®Google Scholar
• Ell C, May A, Gossner L et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett’s esophagus. Gastroenterology 118, 670–677 (2000).
   PubMed Web of Science ®Google Scholar
• Seewald S, Akaraviputh T, Seitz U et al. Circumferential EMR and complete removal of Barrett’s epithelium: a new approach to management of Barrett's esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma. Gastrointest. Endosc. 57, 854–859 (2003).
   PubMed Web of Science ®Google Scholar
• Rajan E, Gostout CJ, Feitoza AB et al. Widespread EMR: A new technique for removal of large areas of mucosa. Gastrointest. Endosc. 60, 623–627 (2004).
   PubMedGoogle Scholar
• Weston AP, Sharma P. Neodymium:yttrium-aluminum garnet contact laser ablation of Barrett’s high grade dysplasia and early adenocarcinoma. Am. J. Gastroenterol. 97, 2998–3006 (2002).
   PubMedGoogle Scholar
• Schulz H, Miehlke S, Antos D et al. Ablation of Barrett’s epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole. Gastrointest. Endosc. 51, 659–663 (2000).
   PubMed Web of Science ®Google Scholar
• van den Boogert J, van Hillegersberg R, Siersema PD, de Bruin RW, Tilanus HW. Endoscopic ablation therapy for Barrett’s esophagus with high-grade dysplasia: a review. Am. J. Gastroenterol. 94, 1153–1160 (1999).
   PubMedGoogle Scholar
• Gossner L, May A, Stolte M, Seitz G, Hahn EG, Ell C. KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett’s esophagus. Gastrointest. Endosc. 49, 8–12 (1999).
   Google Scholar
• Biddlestone LR, Barham CP, Wilkinson SP, Barr H, Shepherd NA. The histopathology of treated Barrett’s esophagus: squamous reepithelialization after acid suppression and laser and photodynamic therapy. Am. J. Surg. Pathol. 22, 239–245 (1998).
   Google Scholar
• Salo JA, Salminen JT, Kiviluoto TA et al. Treatment of Barrett’s esophagus by endoscopic laser ablation and antireflux surgery. Ann. Surg. 227, 40–44 (1998).
   PubMed Web of Science ®Google Scholar
• Eisen GM. Ablation therapy for Barrett’s esophagus. Gastrointest. Endosc. 58, 760–769 (2003).
   Google Scholar
• Sampliner RE. Endoscopic ablative therapy for Barrett’s esophagus: current status. Gastrointest. Endosc. 59, 66–69 (2004).
   Google Scholar
• Grade AJ, Shah IA, Medlin SM, Ramirez FC. The efficacy and safety of argon plasma coagulation therapy in Barrett’s esophagus. Gastrointest. Endosc. 50, 18–22 (1999).
   PubMedGoogle Scholar
• Kahaleh M, Van Laethem JL, Nagy N, Cremer M, Deviere J. Long-term follow-up and factors predictive of recurrence in Barrett’s esophagus treated by argon plasma coagulation and acid suppression. Endoscopy 34, 950–955 (2002).
   PubMed Web of Science ®Google Scholar
• Byrne JP, Armstrong GR, Attwood SE. Restoration of the normal squamous lining in Barrett’s esophagus by argon beam plasma coagulation. Am. J. Gastroenterol. 93, 1810–1815 (1998).
   PubMed Web of Science ®Google Scholar
• Ginsberg GG, Barkun AN, Bosco JJ et al. The argon plasma coagulator: February 2002. Gastrointest. Endosc. 55, 807–810 (2002).
   PubMed Web of Science ®Google Scholar
• Basu KK, Pick B, Bale R, West KP, de Caestecker JS. Efficacy and one year follow up of argon plasma coagulation therapy for ablation of Barrett’s oesophagus: factors determining persistence and recurrence of Barrett’s epithelium. Gut 51, 776–780 (2002).
   PubMed Web of Science ®Google Scholar
• Sampliner RE, Fennerty B, Garewal HS. Reversal of Barrett’s esophagus with acid suppression and multipolar electrocoagulation: preliminary results. Gastrointest. Endosc. 44, 532–535 (1996).
   Web of Science ®Google Scholar
• Kovacs BJ, Chen YK, Lewis TD, DeGuzman LJ, Thompson KS. Successful reversal of Barrett’s esophagus with multipolar electrocoagulation despite inadequate acid suppression. Gastrointest. Endosc. 49, 547–553 (1999).
   Google Scholar
• Sharma P, Sampliner RE, Camargo E. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett’s esophagus. Am. J. Gastroenterol. 92, 582–585 (1997).
   PubMed Web of Science ®Google Scholar
• Sampliner RE, Faigel D, Fennerty MB et al. Effective and safe endoscopic reversal of nondysplastic Barrett’s esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study. Gastrointest. Endosc. 53, 554–558 (2001).
   PubMed Web of Science ®Google Scholar
• Dulai GS, Jensen DM, Cortina G, Fontana L, Ippoliti A. Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett’s esophagus. Gastrointest. Endosc. 61, 232–240 (2005).
   PubMedGoogle Scholar
• Kelty CJ, Ackroyd R, Brown NJ, Stephenson TJ, Stoddard CJ, Reed MW. Endoscopic ablation of Barrett’s oesophagus: a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation. Aliment. Pharmacol. Ther. 20, 1289–1296 (2004).
   PubMed Web of Science ®Google Scholar
• Ackroyd R, Brown NJ, Stephenson TJ, Stoddard CJ, Reed MW. Ablation treatment for Barrett oesophagus: what depth of tissue destruction is needed? J. Clin. Pathol. 52, 509–512 (1999).
   PubMedGoogle Scholar
• Ganz RA, Utley DS, Stern RS, Jackson J, Batts KP, Termin P. Complete ablation of porcine esophageal epithelium using a balloon-based bipolar electrode. Gastrointest. Endosc. 59, AB250 (2004).
   Google Scholar
• Sharma VK, Fleisher DE, Wang KK, Overholt B, Fennerty B. A randomized trial of radio-frequency ablation of specialized intestinal metaplasia of the esophagus. Gastrointest. Endosc. 59, AB113 (2004).
   Google Scholar
• Grana L, Ablin RJ, Goldman S, Milhouse E Jr. Freezing of the esophagus: histological changes and immunological response. Int. Surg. 66, 295–301 (1981).
   Google Scholar
• Dvorakova K, Payne CM, Ramsey L et al. Apoptosis resistance in Barrett’s esophagus: ex vivo bioassay of live stressed tissues. Am. J. Gastroenterol. 100, 424–431 (2005).
   Google Scholar
• Overholt BF, Lightdale CJ, Wang KK et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett’s esophagus: international, partially blinded, randomized Phase III trial. Gastrointest. Endosc. 62(4), 488–498 (2005).
   Google Scholar